IMMUNOTHERAPY Benefit with anti-PD-L1

被引：2
|
作者：
Romero, Diana
机构：
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2017年 / 14卷 / 02期
关键词：
D O I：
10.1038/nrclinonc.2016.218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [1] Benefit with anti-PD-L1
    Diana Romero
    Nature Reviews Clinical Oncology, 2017, 14 : 71 - 71
  • [2] Automated tumor immunophenotyping predicts clinical benefit from anti-PD-L1 immunotherapy
    Li, Xiao
    Eastham, Jeffrey
    Giltnane, Jennifer M.
    Zou, Wei
    Zijlstra, Andries
    Tabatsky, Evgeniy
    Banchereau, Romain
    Chang, Ching-Wei
    Nabet, Barzin Y.
    Patil, Namrata S.
    Molinero, Luciana
    Chui, Steve
    Harryman, Maureen
    Lau, Shari
    Rangell, Linda
    Waumans, Yannick
    Kockx, Mark
    Orlova, Darya
    Koeppen, Hartmut
    JOURNAL OF PATHOLOGY, 2024, 263 (02): : 190 - 202
  • [3] A Novel Anti-PD-L1 Vaccine for Cancer Immunotherapy and Immunoprevention
    Chen, Jie
    Liu, Hui
    Jehng, Tiffany
    Li, Yanqing
    Chen, Zhoushi
    Lee, Kuan-Der
    Shen, Hsieh-Tsung
    Jones, Lindsey
    Huang, Xue F.
    Chen, Si-Yi
    CANCERS, 2019, 11 (12)
  • [4] Discovery of small anti-PD-L1 peptides for cancer immunotherapy
    Liu, Hao
    Zhao, Zhen
    Li, Yuanke
    Cheng, Kun
    CANCER RESEARCH, 2019, 79 (13)
  • [5] ANTI-PD-1 AND ANTI-PD-L1 ANTIBODIES AS IMMUNOTHERAPY AGAINST CANCER: A STRUCTURAL PERSPECTIVE
    Cordova-Bahena, Luis
    Velasco-Velazquez, Marco A.
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2021, 73 (01): : 8 - 16
  • [6] Hair Repigmentation With Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis Reply
    Rivera, Noelia
    Boada, Aram
    Ferrandiz, Carlos
    JAMA DERMATOLOGY, 2018, 154 (01) : 113 - 114
  • [7] In anti-PD-L1 immunotherapy FcγR interaction can add additional benefit depending on the tumor model
    Verbeek, J. S.
    Sow, H. S.
    Benonisson, H.
    Breukel, C.
    Visser, R.
    Verhagen, O.
    Bentlage, A.
    Brouwers, C.
    Claassens, J.
    Linssen, M.
    Camps, M.
    van Hall, T.
    Ossendorp, F.
    Herbert-Fransen, M.
    Vidarsson, G.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1733 - 1734
  • [8] Intestinal microbiota may dynamically facilitate the anti-PD-L1 immunotherapy
    Xue, Jia
    Wang, Zhun
    Guo, Sheng
    Cai, Jie
    Ouyang, Davy
    Cai, Bin
    Chen, Gang
    Liu, Jie
    Dong, Xin
    Li, Henry
    CANCER RESEARCH, 2017, 77
  • [9] MYASTHENIA GRAVIS CRISIS COMPLICATING ANTI-PD-L1 CANCER IMMUNOTHERAPY
    Chae, June
    Peikert, Tobias
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 280 - 280
  • [10] Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy
    Mamani, Umar-Farouk
    Ibrahim, Mohammed Nurudeen
    Liu, Yanli
    Fetse, John
    Lin, Chien-Yu
    Kandel, Sashi
    Nakhjiri, Maryam
    Koirala, Sushil
    Guo, Yuhan
    Alahmari, Mohammed
    Cheng, Kun
    PHARMACEUTICAL RESEARCH, 2024, : 2275 - 2288
12345